Business Context and Reporting Period
This Form 6-K filing by BiondVax Pharmaceuticals Ltd. (not Scinai Immunotherapeutics Ltd.) covers the month of July 2020, with a filing date of July 28, 2020. The document serves as a notice to shareholders regarding the scheduling of the Company's Annual General Meeting.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this document.
Guidance, Outlook, and Management Commentary
The Company has scheduled its Annual General Meeting of Shareholders for September 2, 2020, at 4:00 p.m. Israel time. The meeting will be held at the offices of Gross, Kleinhendler, Hodak, Halevy, Greenberg, Shenhav & Co. in Tel Aviv, Israel. A Notice of the meeting is included as Exhibit 99.1 and incorporated by reference into the Company's Registration Statement on Form S-8.
Key Facts for Investor Verification
- Verify the correct registrant name is BiondVax Pharmaceuticals Ltd., not Scinai Immunotherapeutics Ltd.
- Confirm the Annual General Meeting date of September 2, 2020, and the location in Tel Aviv.
- Note that this filing contains no financial results or operational updates.
- Review Exhibit 99.1 for the full Notice of the Annual General Meeting.